(Q41028709)

25 September 2017

Tobramycin and gentamicin concentrations in the serum of normal and anephric patients (English)

1 reference

25 September 2017

0 references

Lockwood WR

1

1 reference

25 September 2017

Bower JD

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 January 1973

1 reference

Antimicrobial Agents and Chemotherapy

25 September 2017

1 reference

25 September 2017

3

1 reference

25 September 2017

1

1 reference

25 September 2017

125-129

1 reference

Tobramycin (Nebramycin Factor 6): In Vitro Activity Against Pseudomonas aeruginosa

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Tobramycin: in vitro activity and comparison with kanamycin and gentamicin

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

In vitro susceptibility testing with tobramycin

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

In Vitro Evaluation of Tobramycin, a New Aminoglycoside Antibiotic

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

In Vitro Studies of Tobramycin, an Aminoglycoside Antibiotic

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Cross-Resistance of Pseudomonas to Gentamicin and Tobramycin

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Pharmacologic Studies on Tobramycin and Comparison with Gentamicin

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Dose of gentamicin in patients with normal renal function and renal impairment.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Blood levels of ampicillin, kanamycin and gentamicin in the uremic patient

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444371

Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration

19 August 2018

1 reference

12 December 2020

Rapid microassay for circulating nephrotoxic antibiotics

1 reference

12 December 2020

Preclinical assessment of the antibacterial activity of nebramycin factor 6

1 reference

12 December 2020

Correlation of Serum Creatinine Concentration and Gentamicin Half-Life

1 reference

12 December 2020

Parenteral administration of gentamicin in renal failure: patients undergoing intermittent haemodialysis

1 reference

12 December 2020

Preliminary studies with nebramycin factor 6

1 reference

12 December 2020

A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels

1 reference

12 December 2020

GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.3.1.125

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

4790568

1 reference